Stockscreener 앱 받기
22.20
4.57%
0.97
시간 외 거래:
22.20
전일 마감가:
$21.23
열려 있는:
$21.23
하루 거래량:
34,425
Relative Volume:
0.79
시가총액:
$37.80M
수익:
$7.10M
순이익/손실:
$-31.59M
주가수익비율:
-8.5057
EPS:
-2.61
순현금흐름:
$-26.75M
1주 성능:
+5.76%
1개월 성능:
+38.32%
6개월 성능:
+23,492%
1년 성능:
+2,506%
1일 변동 폭
$20.85
$23.00
1주일 범위
$20.30
$23.00
52주 변동 폭
$0.0866
$31.00
Palatin Technologies Inc. Stock (PTN) Company Profile
명칭
Palatin Technologies Inc.
전화
609-495-2200
주소
Cedar Brook Corporate Center, 4B Cedar Brook Drive, Cranbury, NJ
Compare PTN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PTN
Palatin Technologies Inc.
|
22.20 | 36.15M | 7.10M | -31.59M | -26.75M | -2.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Palatin Technologies Inc. Stock (PTN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-12 | 개시 | Laidlaw | Buy |
| 2025-12-03 | 개시 | Alliance Global Partners | Buy |
| 2015-06-05 | 재확인 | Canaccord Genuity | Buy |
| 2015-01-12 | 재확인 | ROTH Capital | Buy |
| 2012-05-23 | 개시 | Noble Financial | Buy |
| 2007-01-23 | 개시 | Next Generation | Buy |
모두보기
Palatin Technologies Inc. 주식(PTN)의 최신 뉴스
Dry Eye Disease Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Palatin Technologies, Novaliq, mc2 therapeutics - Barchart.com
PTN Should I Buy - Intellectia AI
Palatin Techs (PTN) Stock Analysis Report | Financials & Insights - Benzinga España
Palatin Technologies (PINK:PTNT) Share Price Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World
Palatin to test 2 obesity-targeting drugs for PWS in clinical trials this year - Prader-Willi Syndrome News
Palatin Technologies Q2 Earnings Call Highlights - Defense World
Palatin Technologies’ Rare-Obesity Strategy Sets Up a Catalyst-Rich 2026 for Its MC4R Pipeline (NYSE: PTN) - The Globe and Mail
Palatin Technologies, Inc. (AMEX:PTN) Q2 2026 Earnings Call Transcript - Insider Monkey
Palatin Technologies' Rare-Obesity Strategy Sets Up a Catalyst-Rich 2026 for Its MC4R Pipeline (NYSE: PTN) - TradingView
Earnings call transcript: Palatin Technologies Q2 2026 reveals challenges By Investing.com - Investing.com South Africa
Palatin Technologies Inc (PTN) Q2 2026 Earnings Call Highlights: Strategic Advances Amid Rising Losses - GuruFocus
Earnings call transcript: Palatin Technologies Q2 2026 reveals challenges - Investing.com Australia
PTN: Strengthened cash position and advanced rare obesity pipeline with key clinical milestones ahead - TradingView
PALATIN TECHNOLOGIES INC SEC 10-Q Report - TradingView
Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update - The Malaysian Reserve
PTN | Palatin Technologies, Inc. Analyst Forecasts - Quiver Quantitative
PTN | Palatin Technologies, Inc. Insider Trading - Quiver Quantitative
Palatin Technologies Q2 revenue rises yr/yr, net loss widens - TradingView
PTN: MC4R obesity programs advance to clinical trials as cash position strengthens and net loss widens - TradingView
Palatin funds new obesity drug trials for hypothalamic obesity, PWS - Stock Titan
Palantin Technologies to enact 1-for-50 reverse stock split - MSN
Head-To-Head Contrast: Palatin Technologies (PINK:PTNT) vs. Akorn (OTCMKTS:AKRXQ) - Defense World
Calliditas Therapeutics AB (publ) (NASDAQ:CALT) & Palatin Technologies (PINK:PTNT) Critical Analysis - Defense World
Palatin initiated with a Buy at LaidlawRhythm Pharmaceuticals - MSN
The Truth About Palatin Technologies (PTN): Tiny Biotech, Huge Hype – But Is It Worth Your Money? - AD HOC NEWS
Palatin Technologies (PINK:PTNT) Stock Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World
Palatin Technologies Targets Hypothalamic Obesity as Next Frontier Beyond GLP-1s (NYSE: PTN) - TradingView — Track All Markets
Here's Why Palatin Technologies (PTN) Is a Great 'Buy the Bottom' Stock Now - MSN
Palatin Technologies (PINK:PTNT) Stock Price Passes Above 200 Day Moving Average – Should You Sell? - Defense World
Palatin Technologies (PTNT) Stock Forecast and Price Target 2026 - MarketBeat
Palatin Technologies (PTN) officer reports Form 4 tax-withheld shares - Stock Titan
Palatin Technologies (PTN) CEO Carl Spana details tax share withholdings - Stock Titan
Palatin finishes phase 2 trial in obesity treatment study - MSN
Palatin Technologies (PINK:PTNT) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Palatin Technologies (PTN) CFO/COO reports 565-share insider stock sale - Stock Titan
PTN (PTN) holder plans Rule 144 sale of 565 common shares - Stock Titan
Comparing Clever Leaves (NASDAQ:CLVR) and Palatin Technologies (PINK:PTNT) - Defense World
Palatin Technologies, Inc.(NYSEAM: PTN) added to S&P TMI Index - marketscreener.com
Decliners Report: How Palatin Technologies Inc. (PTN) stock reacts to new regulationsEarnings Miss & Long Hold Capital Preservation Tips - Улправда
Palatin Technologies Earnings Notes - Trefis
How Palatin Technologies Inc. (PTN) stock reacts to new regulationsTrade Risk Assessment & Capital Efficiency Focused Strategies - Улправда
Palatin Technologies Inc trading resumes - MSN
Palatin Technologies (PINK:PTNT) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
Why Is Palatin Technologies, Inc. (PTN) Stock Up Today? - Meyka
Laidlaw Begins Coverage on Palatin Technologies (NYSEAMERICAN:PTN) - Defense World
JANUS HENDERSON GROUP PLC Acquires Shares in Palatin Technologies Inc - GuruFocus
Palatin Techs (PTN) Receives 'Buy' Rating from Laidlaw & Co. | P - GuruFocus
Laidlaw initiates coverage on Palatin Technologies stock with Buy rating By Investing.com - Investing.com Australia
Laidlaw initiates coverage on Palatin Technologies stock with Buy rating - Investing.com
Palatin Technologies (PTN) executive Wills records vested RSUs and options - Stock Titan
Palatin Technologies (PTN) director awarded new 2011 Plan stock options - Stock Titan
Palatin Technologies Inc. (PTN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.69%
0.68%
자본화:
|
볼륨(24시간):